About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Rationale for Neuromodulation Focused Therapeutics for Cardiac Disease
By
Jeffrey Ardell
713 views
May 20, 2021
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
17:33
CVRx | Barostim
Beyond BeAT-HF: Real World Experience with Barostim
Feat.
G. Panjrath
15:57
CVRx | Barostim
Long-Term Results of the BeAT-HF Clinical Study
Feat.
J. Lindenfeld
11:18
CVRx | Barostim
Barostim and the Window of Opportunity in Class II/III HFrEF Patient…
Feat.
G. Panjrath,
D. Yaranov,
J. Lindenfeld,
J. Thomas Heywood
10:21
CVRx | Barostim
Patient Identification and Post-Implant Management within an Advance…
Feat.
D. Yaranov
13:58
CVRx | Barostim
Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)
Feat.
J. Thomas Heywood
18:26
CVRx | Barostim
HFA 2023: Unlocking the Potential of Baroreflex Activation in Heart …
Feat.
F. Zannad,
J. Lindenfeld,
M. Fudim
16:32
CVRx | Barostim
ESC 2023: BeAT-HF: Long term outcome
Feat.
M. Zile
09:58
CVRx | Barostim
Barostim for HFrEF Patients
Feat.
P. Mccann
16:00
CVRx | Barostim
HFA 2023: BeAT-HF: Long-Term Safety Profile and Outcomes
Feat.
F. Zannad
11:43
CVRx | Barostim
ESC 2023: Real-world experience with Baroreflex Activation Therapy
Feat.
F. Arribas
07:52
CVRx | Barostim
VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…
Feat.
C. Darling
06:59
CVRx | Barostim
VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Proc…
Feat.
C. Darling,
M. PEREZ-IZQUIERDO
07:42
CVRx | Barostim
HFA 2023: Autonomic Dysfunction in HFrEF
Feat.
M. Fudim
18:36
CVRx | Barostim
Barostim and the Window of Opportunity in Class II/III HFrEF Patient…
Feat.
W. Abraham,
G. Panjrath,
D. Yaranov,
P. Mccann
06:23
CVRx | Barostim
ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…
Feat.
W. Abraham,
F. Arribas,
M. Zile
11:49
CVRx | Barostim
ESC 2023: Unmet needs and opportunities with device therapies of HFr…
Feat.
W. Abraham
06:16
CVRx | Barostim
Challenges and Opportunities with Contemporary GDMT
Feat.
D. Yaranov
11:59
CVRx | Barostim
Patient Identification to Follow-up And New Implant Approach
Feat.
J. Allred
11:23
CVRx | Barostim
Baroreflex Activation Therapy: What Has Real-World Experience Taught…
Feat.
J. Bauersachs
11:51
CVRx | Barostim
Unlocking the Potential of Baroreflex Activation Therapy (BAT) for H…
Feat.
M. Fudim,
J. Bauersachs,
W. Abraham